Split-course Chemoradiotherapy for Local Advanced NSCLC With Impaired Baseline Pulmonary Function
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This Phase II randomized study is to determine the efficacy of split-course chemoradiotherapy
for local advanced non-small cell lung cancer with severe impairment of baseline pulmonary
function.